ロード中...
Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies
Optimum efficacy is the primary goal for any cancer therapy, and entails controlling tumour growth and prolonging survival as far as possible. The prognosis for patients with metastatic renal cell carcinoma (mRCC) has greatly improved with the introduction of targeted therapies. This review examines...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3049574/ https://ncbi.nlm.nih.gov/pubmed/21285971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6606084 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|